Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system

Virus Research

Volumn 62, Issue 2, 1999, Pages 149-158

  Kandolf, Reinhard ^a   Sauter, Martina ^a   Aepinus, Christian ^a   Schnorr, Jens Jörg ^a   Selinka, Hans Christoph ^a   Klingel, Karin ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

B lymphocytes; Coxsackievirus; Dilated cardiomyopathy; Myocarditis; Picornavirus; Restricted replication; Viral cytotoxicity

Indexed keywords

COMPLEMENTARY DNA; VIRUS RNA;

B LYMPHOCYTE; CELLULAR IMMUNITY; COXSACKIE VIRUS; ENTEROVIRUS; ENTEROVIRUS INFECTION; HEART DILATATION; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; MOUSE; MUSCLE CELL; MYOCARDITIS; NONHUMAN; PERSISTENT INFECTION; PICORNAVIRUS; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

COXSACKIEVIRUS; ENTEROVIRUS; MURINAE; PICORNAVIRIDAE;

EID: 0032801969     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(99)00041-6     Document Type: Article

References (46)

1. Anderson D., Wilson J.E., Carthy C.M., Yang S., Kandolf R., McManus B.M. Direct interaction of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J. Virol. 70:1996;4632-4645.
2. Althage A., Odermatt B., Moskophidis D., Kundig T., Hoffman-Rohrer U., Hengartner H., Zinkernagel R.M. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur. J. Immunol. 22:1992;1803-1812.
3. Clark M.E., Lieberman P.M., Berk A.J., Dasgupta A. Direct cleavage of a human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol. Cell Biol. 13:1993;1232-1237.
4. Craighead J.E., Huber S.A., Sriram S. Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease. Lab. Invest. 63:1990;432-446.
5. Foulis A.K., Farquharson M.A., Cameron S.O., McGill M., Schönke H., Kandolf R. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with Type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackie viral myocarditis. Diabetologia. 33:1990;290-298.
6. Franz W.M., Breves D., Klingel K., Brem G., Hofschneider P.H., Kandolf R. Heart-specific targeting of firefly luciferase by myosin-light-chain-2 promoter and developmental regulation in transgenic mice. Circ. Res. 73:1993;629-638.
7. Gray D., Skarvall H. B-cell memory is short-lived in the absence of antigen. Nature. 336:1988;70-73.
8. Gray D. Immunological memory. Annu. Rev. Immunol. 11:1993;49-77.
9. Heim A., Canu A., Kirschner P., Simon T., Mall G., Hofschneider P.H., Kandolf R. Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3 infected carrier cultures of human myocardial fibroblasts. J. Infect. Dis. 166:1992;958-965.
10. Heim A., Brehm C., Stille-Siegener M., Müller G., Hake S., Kandolf R., Figulla H.R. Cultured human myocardial fibroblasts of pediatric origin: Natural human interferon-alpha is more effective than recombinant interferon-alpha-2a in carrier-state coxsackievirus B3 replication. J. Mol. Cardiol. 27:1995;2199-2208.
11. Herskowitz A., Wolfgram L.J., Rose N.R., Beisel K.W. Coxsackievirus B3 murine myocarditis-marked strain differences in histopathologic features of early and late phase myocarditis. J. Am. Coll. Cardiol. 9:1987;1311-1319.
12. Hohenadl C., Klingel K., Rieger P., Hofschneider P.H., Kandolf R. Investigation of the coxsackievirus B3 non-structural proteins 2B, 2C, and 3AB: generation of specific polyclonal antisera and detection of replicating virus in infected tissue. J. Virol. Methods. 47:1994;279-295.
13. Huber M., Selinka H.-C., Kandolf R. Tyrosine phosphorylation events during coxsackievirus B3 replication. J. Virol. 71:1997;595-600.
14. Kandolf R. The impact of recombinant DNA technology on the study of enterovirus heart disease. Bendinelli M., Friedman H. Coxsackieviruses - a general update. 1988;293-318 Plenum Press, New York.
15. Kandolf R. Enterovirus myocarditis and dilated cardiomyopathy. Med. Klin. 93:1998;215-222.
16. Kandolf R., Hofschneider P.H. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. USA. 82:1985;4818-4822.
17. Kandolf R., Hofschneider P.H. Enteroviral heart disease. Springer Sem. Immunopathol. 11:1989;1-13.
18. Kandolf R., Canu A., Hofschneider P.H. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell. Cardiol. 17:1985;167-181.
19. Kandolf R., Kirschner P., Ameis D., Canu A., Hofschneider P.H. Cultured human heart cells: a model system for the study of the antiviral activity of interferons. Eur. Heart. J. 8((suppl.)):1987;453-456.
20. Kandolf R., Klingel K., Zell R., Selinka H.-C., Raab U., Schneider-Brachert W., Bültmann B. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. Intervirology. 35:1993;140-151.
21. Kilborne E., Horsfall F. Lethal infections with coxsackievirus of adult mice given cortisone. Proc. Soc. Biol. Med. 77:1951;135-138.
22. King P.D., Katz D.R. Mechanisms of dendritic cell function. Immunol. Today. 6:1990;206-211.
23. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage and inflammation. Proc. Natl. Acad. Sci. USA. 89:1992;314-318.
24. Klingel K., Kandolf R. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. Scand. J. Infect. Dis. Suppl. 88:1993;79-85.
25. Klingel K., Stephan S., Sauter M., Zell R., McManus B.M., Bültmann B., Kandolf R. Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets. J. Virol. 70:1996;8888-8895.
26. Klingel K., Rieger P., Mall G., Selinka H.-C., Huber M., Kandolf R. Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: Identification of target cells and cytopathic effects. Lab. Invest. 78:1998;1227-1237.
27. Klump W.M., Bergmann I., Müller B.C., Ameis D., Kandolf R. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64:1990;1573-1583.
28. Lamphear B., Yan R., Yang F., Waters D., Liebig H.D., Klump H., Kuechler E., Skern T., Rhoads R.E. Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human coxsackievirus and rhinovirus. J. Biol. Chem. 268:1993;19200-19203.
29. Lee K.J., Ross R.S., Rockman H.A., Harris A.N., O'Brien T.X., van Bilsen M., Shubeita H.E., Kandolf R., Brem G., Price J., Evans S.M., Zhu H., Franz W.M., Chien K.R. Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. J. Biol. Chem. 267:1992;15875-15885.
30. Lodge P.A., Herzum M., Olszewski J., Huber S.A. Coxsackievirus B3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am. J. Pathol. 3:1987;455-463.
31. Matteucci D.A., Toniolo P., Conaldi G., Basolo F., Gori Z., Bendinelli M. Systemic lymphoid atrophy in coxsackievirus B3-infected mice: Effects of virus and immunopotentiating agents. J. Infect. Dis. 151:1985;1100-1108.
32. Martino T., Liu P., Sole M.J. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 74:1994;182-188.
33. McManus B.M., Kandolf R. Evolving concepts of cause, consequence, and control in myocarditis. Curr. Opin. Cardiol. 6:1991;418-427.
34. Melnick J.L. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Fields B.N., Knipe D.M., Howley P.M. Virology. 1996;655-671 Lippincott-Raven publishers, Philadelphia.
35. Muir P., Kämmerer U., Korn K., Mulders M.N., Pöyry T., Weissbrich B., Kandolf R., Cleator G.M., van Loon A.M. Molecular typing of enteroviruses: Current status and future requirements. Clin. Microbiol. Rev. 11:1998;202-227.
36. Schmaltz A., Demel K.P., Kallenberg R., Neudorf U., Kandolf R., Klingel K., Bültmann B. Immunosuppressive therapy of chronic myocarditis in children: Three cases and the design of a randomized prospective trial of therapy. Pediatr. Cardiol. 19:1998;235-239.
37. Sha W.C., Liou H.C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
38. Szakal A.K., Kosco M.H., Tew J.G. Microanatomy of lymphoid tissue during humoral immune responses: structure function relationships. Annu. Rev. Immunol. 7:1989;91-109.
39. Vuorinen T., Vainionpää R., Kettinen H., Hyypiä T. Coxsackievirus B3 infection in human leukocytes and lymphoid cell lines. Blood. 84:1994;823-829.
40. Whitton J.L., Oldstone M.B.A. Immune response to viruses. Fields B.N., Knipe D.M., Howley P.M. Virology. 1996;345-374 Lippincott-Raven publishers, Philadelphia.
41. Werner S., Klump W.M., Schönke H., Hofschneider P.H., Kandolf R. Expression of coxsackievirus B3 proteins in Escherichia coli and generation of virus-specific antisera. DNA. 7:1988;307-316.
42. Wessely R., Henke A., Zell R., Kandolf R., Knowlton K.U. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: An approach to the study of enteroviral persistence in cardiac myocytes. Circulation. 98:1998;450-457.
43. Wessely R., Klingel K., Santana L.F., Dalton N., Hongo M., Lederer W.J., Kandolf R., Knowlton K. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Invest. 102:1998;1444-1453.
44. Yalamanchili P., Harris K., Wimmer E., Dasgupta A. Inhibition of basal transcription by poliovirus: a virus-encoded protease (3C pro) inhibits formation of TBP-TATA box complex in vitro. J. Virol. 70:1996;2922-2929.
45. Yang Y.L., Reis L.F., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams R.R., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:1995;6095-6106.
46. Zhu Z., Tang W., Ray A., Wu Y., Einarsson O., Landry M.L., Gwaltney J. Jr., Elias J.A. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J. Clin. Invest. 97:1996;421-430.